Mokgethi, Nomcebo Oratile
Christofides, Nicola
Machisa, Mercilene
Akpomiemie, Godspower
Lalla-Edward, Samantha
Article History
Received: 23 November 2021
Accepted: 22 April 2022
First Online: 12 May 2022
Declarations
:
: The primary study was approved by the drug regulator (the South African Health Products Regulatory Authority), local research authority (Johannesburg Health District Research Committee), and the local institutional review board (University of the Witwatersrand Human Research Ethics Committee), and overseen by an independent data safety monitoring board (DSMB) (150705B). This trial is registered with ClinicalTrials.gov, number ExternalRef removed; confirming that all experiments were performed in accordance with relevant South African regulatory guidelines and regulations. All participants provided written informed consent before the study. Ethical clearance was obtained from the University of the Witwatersrand Human Research Ethic Committee (Medical) for the secondary data analysis (M181001). All participants provided written informed consent before study commencement.
: Not applicable.
: The authors declare that they have no competing interests.